Email Updates

You are here

Home»Media

AVAC in the News

  • AIDS vaccine study reassures skeptics

    The fog around the largest AIDS vaccine study ever conducted began to lift today, as Thai and U.S. researchers for the first time publicly presented a detailed analysis of their data to over 1000 scientists gathered here at an annual meeting.

    October 20, 2009
    HIV Vaccine
    Science Insider

  • Data Call Into Question HIV Study Results

    Researchers from the U.S. Army and Thailand announced last month they had found the first vaccine that provided some protection against HIV. But a second analysis of the $105 million study, not disclosed publicly, suggests the results may have been a fluke, according to AIDS scientists who have seen it.

    October 12, 2009
    HIV Vaccine
    Wall Street Journal

  • For first time, AIDS vaccine shows some success

    The vaccine — known as RV 144, a combination of two genetically engineered vaccines, neither of which had worked before in humans — was declared a qualified success after a six-year clinical trial on more than 16,000 volunteers in Thailand. Those who were vaccinated became infected at a rate nearly one-third lower than the others, the sponsors said Thursday morning.

    September 24, 2009
    HIV Vaccine
    New York Times

  • New Web Site Seeks to Fight Myths About Circumcision and H.I.V.

    Trying to fight misconceptions about the link between H.I.V. transmission and circumcision.

    March 3, 2009
    Voluntary Medical Male Circumcision
    New York Times

  • Indevus' sex gel shows first AIDS protection in women

    A vaginal gel made by Indevus Pharmaceuticals Inc. showed first signs that such a product might protect women from the AIDS virus.

    February 9, 2009
    Microbicides
    Bloomberg

  • Can HIV infection be prevented with a once-daily pill?

    Nearly four years after political pressure shut down two trials that would have tested whether a once-a-day pill could prevent high-risk HIV-negative people from catching the AIDS-causing virus, there’s a surge of renewed interest in the concept, known as Pre-Exposure Prophylaxis, or PrEP.

    December 1, 2008
    PrEP
    Scientific American

  • Circumcision clinic has African men lining up to prevent AIDS

    Since a study by Bailey in 2006 found the operation drops the HIV infection rate in men by 60 percent, the procedure most often performed at birth has become a popular elective surgery among grown men in southern Africa.

    July 31, 2008
    Voluntary Medical Male Circumcision
    Bloomberg

  • HIV vaccine trial cancelled

    The trial, called PAVE 100, would have tested whether a vaccine could help control HIV infection. The vaccine regimen was developed by the NIAID’s Vaccine Research Center and comprised a DNA vaccine containing HIV genes, with a modified cold virus carrying HIV genes as a booster.

    July 18, 2008
    HIV Vaccine
    Nature

  • US scraps plan to test AIDS vaccine

    The US National Institutes of Health scrubbed plans to test its AIDS vaccine due to concerns about its safety and effectiveness, 10 months after the collapse of a clinical trial for a similar vaccine from Merck & Co.

    July 18, 2008
    HIV Vaccine
    Wall Street Journal

Pages